Navigation Links
Canary Foundation's Dr. Sanjiv Sam Gambhir Elected to the National Academies Institute of Medicine
Date:10/21/2008

SAN JOSE, Calif., Oct. 21 /PRNewswire/ -- Canary Foundation, a nonprofit organization that funds research in early cancer detection, announced that its Scientific Program Director, Dr. Sanjiv Sam Gambhir, has been elected as a new member of the U.S. National Academies Institute of Medicine (IOM). This is one of the highest honors in the fields of health and medicine. The IOM, established in 1970 by the National Academy of Sciences, serves as adviser to the nation to improve health. Dr. Gambhir was one of the 65 new members and five foreign associates acknowledged by IOM for their professional achievements and dedication in the areas of health care, prevention of disease, education, or research. He is also one of the youngest members ever elected to the IOM.

"I am deeply honored and humbled by this election to membership," said Dr. Sanjiv Sam Gambhir. "Medicine has such a profound impact in our lives and I look forward to applying my training, knowledge and passion in cancer research at the Institute of Medicine, which has been at the forefront of our nation's health and science policy issues."

Dr. Gambhir serves as Canary Scientific Program Director where he leads the Canary science team of leaders in the fields of proteomics, imaging, genomics, epigenomics, oncology and subject matter specialists in ovarian, pancreatic, prostate and lung cancer from the best universities, hospitals and research institutions in the world.

He is a professor of radiology and bioengineering at Stanford University, where he serves as chief of the nuclear medicine division and director of the Molecular Imaging Program at Stanford (MIPS). He is a principal investigator for the National Cancer Institute (NCI) Center for Cancer Nanotechnology Excellence U54 and the In Vivo Cellular & Molecular Imaging Center P50 grants, and is the program director for a NCI T32 post-doctoral fellowship molecular imaging training grant.

Dr. Gambhir serves on numerous corporate scientific advisory boards and the NCI scientific advisory board. His many honors include the Paul C. Aebersold Award from the Society of Nuclear Medicine, Hounsfield Medal from Imperial College London, the Distinguished Clinical Scientist Award from the Doris Duke Charitable Foundation, the Holst Medal, the Taplin Award and the Tesla Medal. In 2007, Dr. Gambhir also co-hosted a Nobel Symposium in Stockholm on Molecular Imaging.

"At Canary Foundation where saving lives -- through detecting cancer at the earliest stage -- is our mission, we've been honored to have Sam Gambhir head our scientific teams and we are confident that he will have much to contribute as an active member at the Institute of Medicine," said Don Listwin, founder and chairman of Canary Foundation.

About Canary Foundation

Canary Foundation is a non-profit dedicated to the goal of identifying cancer early through a simple blood test and then isolating it with imaging. Since 2004, Canary has raised over $27.9 million in pledges towards its goal of $100 million for early detection research. Its collaborative research programs span multiple disciplines and institutions. 100% of donations go to early detection research activities. For more information, please visit http://www.canaryfoundation.org.


'/>"/>
SOURCE Canary Foundation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Graphene gazing gives glimpse of foundations of universe
2. Douglas Oberhelman Elected to Lilly Board of Directors
3. Netsmart Technologies Selected by City and County of San Francisco to Provide Integrated Behavioral Healthcare Software System
4. NEXCORE Technology Selected to Manufacture New Endoscopic Cryotherapy Device
5. Fujitsu PalmSecure and HT Systems PatientSecure Selected by BayCare Health System to Protect Patient Confidentiality and Prevent Medical Identity Theft
6. JD Technologies, LLC Selected by FCT Ingenieurkeramik GmbH to Represent Their High Performance Ceramic Expertise In the United States
7. Animetrics Inc. Selected to Provide 3D Face Viewer Technology for United States Army Biometric Automated Toolset (BAT)
8. Schering-Plough Announces Closing of Planned Divestiture of Selected Animal Health Products
9. Sparta Systems Selected by Genzyme to Optimize Quality Assurance Processes with TrackWise
10. Cardium Selected for Inclusion in Russell Microcap Index
11. Governor Perdue Announces Georgia Selected as Home for New National Health Museum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
(Date:6/23/2016)... SANTA MONICA, Calif. , June 23, 2016  The Prostate Cancer ... to pioneer increasingly precise treatments and faster cures for prostate cancer. Members of ... 77 institutions across 15 countries. Read More About the ... ... ...
(Date:6/23/2016)... , ... June 23, 2016 , ... In a new ... in Denmark detail how a patient who developed lymphedema after being treated for breast ... results could change the paradigm for dealing with this debilitating, frequent side effect of ...
Breaking Biology Technology:
(Date:4/15/2016)... 15, 2016 Research and ... Biometrics Market 2016-2020,"  report to their offering.  , ... , ,The global gait biometrics market is expected ... the period 2016-2020. Gait analysis generates ... be used to compute factors that are not ...
(Date:4/13/2016)...  IMPOWER physicians supporting Medicaid patients in ... standard in telehealth thanks to a new partnership with ... IMPOWER patients can routinely track key health measurements, such ... and, when they opt in, share them with IMPOWER ... local retail location at no cost. By leveraging this ...
(Date:3/31/2016)... March 31, 2016  Genomics firm Nabsys has completed ... Barrett Bready , M.D., who returned to the ... original technical leadership team, including Chief Technology Officer, ... Development, Steve Nurnberg and Vice President of Software and ... company. Dr. Bready served as CEO of ...
Breaking Biology News(10 mins):